Index/Organizations/American Association of Clinical Endocrinology

American Association of Clinical Endocrinology

Professional community of physicians

Fact-Checks

5 results

Nov 17, 2025

What are the 2025 ACC/AHA cholesterol guideline thresholds for statin initiation by 10-year ASCVD risk?

The available sources show that 2025 ACC/AHA guidance — as reflected in the 2025 Acute Coronary Syndromes (ACS) guideline and related summaries — keeps aggressive lipid management in high-risk and sec...

Feb 2, 2026

How can consumers verify if a diabetes treatment claim has peer‑reviewed clinical evidence?

A reliable shortcut: look for clinical studies published in s, preferably randomized controlled trials or systematic reviews, and then check study design transparency, replication, and endorsement by ...

Dec 4, 2025

Are there position statements from endocrinology or diabetes societies about GlucoSense safety and efficacy?

No major endocrinology or diabetes professional society has a named position statement about any product called “GlucoSense” in the supplied sources; instead, reporting shows two distinct uses of the ...

Nov 29, 2025

What do major guidelines (ADA, AAN) recommend for treating diabetic peripheral neuropathy?

Major U.S. guidelines treat painful diabetic peripheral neuropathy (DPN) as symptom-management plus prevention: the ADA emphasizes glycemic control to prevent or slow DPN and recommends gabapentinoids...

Nov 19, 2025

How do comorbidities (diabetes, CKD, familial hypercholesterolemia) change statin initiation recommendations in 2025?

Major 2024–2025 guidelines and reviews treat diabetes, chronic kidney disease (CKD), and familial hypercholesterolemia (FH) as “statin‑indicated” or risk‑enhancing conditions that lower the threshold ...